Webcast Nucleic Acid Detection Methods for the SARS-Cov2 virus

Nucleic Acid Detection Methods for the SARS-Cov2 virus

 · Australia/NSW

About This Webcast

Nucleic acid-based testing (NAT) for SARS-Cov2, the virus which underlies COVID-19, is currently the most sensitive approach available for early detection of the disease. As the COVID-19 pandemic expands at an unprecedented rate, it is evident that huge efforts need to be made to scale up current SARS-Cov2 NAT. There is pressing need to evaluate alternative protocols, reagents, and methods to allow NAT to continue in the face of potential shortages. As a result, there has been an explosion in the number of papers evaluating potential advances, comparable reagents, and alternatives to the “gold-standard” RT-qPCR test recommended by the Centers for Disease Control. In this webinar, Dr. Selva Ramasubramanian will review both current and emerging nucleic acid based-tests used in SARS-Cov2 detection. These include: PCR Amplification – RT-PCR, One-Step and Two-Step RT-qPCR Isothermal Amplification – RT-LAMP and RAMP CRISPR Diagnostics – SHERLOCK and DETECTR RNA Sequencing – LAMP-Seq

Speakers

Selva Ramasubramanian, PhD

Selva Ramasubramanian, PhD

Field Application Scientist , New England Biolabs

Selva Ramasubramanian, PhD,is a Field Application Scientist at New England Biolabs, ANZ. Selva received her PhD from the Max Planck Institute (MPIPZ, Germany) and moved to Australia as a visiting scientist at Monash University (Department of Biological Science, Melbourne). Selva also has Biopharmaceutical experience (Biocon Biopharmaceuticals) in Bioanalytical Division - Monoclonal Antibody Characterization. Selva joined the Monash Health Translation Precinct (MHTP) - Core Medical Genomics Facility as Single Cell Genomics Manager. In the Genomics space, she possesses broad knowledge including Project Design consultations, significant hands-on experience with different Genomic platforms and technical capabilities.